GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » D&D Pharmatech Inc (XKRX:347850) » Definitions » Price-to-Tangible-Book

D&D Pharmatech (XKRX:347850) Price-to-Tangible-Book : 58.76 (As of Jun. 21, 2024)


View and export this data going back to 2024. Start your Free Trial

What is D&D Pharmatech Price-to-Tangible-Book?

As of today (2024-06-21), D&D Pharmatech's share price is ₩28900.00. D&D Pharmatech's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was ₩491.81. Hence, D&D Pharmatech's Price to Tangible Book Ratio of today is 58.76.

The historical rank and industry rank for D&D Pharmatech's Price-to-Tangible-Book or its related term are showing as below:

XKRX:347850' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 0   Med: 0   Max: 57.44
Current: 56.53

During the past 6 years, D&D Pharmatech's highest Price to Tangible Book Ratio was 57.44. The lowest was 0.00. And the median was 0.00.

XKRX:347850's Price-to-Tangible-Book is ranked worse than
98.43% of 1209 companies
in the Biotechnology industry
Industry Median: 2.6 vs XKRX:347850: 56.53

A closely related ratio is called PB Ratio. As of today, D&D Pharmatech's share price is ₩28900.00. D&D Pharmatech's Book Value per Sharefor the quarter that ended in Dec. 2023 was ₩4,472.98. Hence, D&D Pharmatech's P/B Ratio of today is 6.46.

D&D Pharmatech Price-to-Tangible-Book Historical Data

The historical data trend for D&D Pharmatech's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

D&D Pharmatech Price-to-Tangible-Book Chart

D&D Pharmatech Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Tangible-Book
Get a 7-Day Free Trial - - - - -

D&D Pharmatech Quarterly Data
Dec22 Sep23 Dec23
Price-to-Tangible-Book - - -

Competitive Comparison of D&D Pharmatech's Price-to-Tangible-Book

For the Biotechnology subindustry, D&D Pharmatech's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

D&D Pharmatech's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, D&D Pharmatech's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where D&D Pharmatech's Price-to-Tangible-Book falls into.


D&D Pharmatech Price-to-Tangible-Book Calculation

D&D Pharmatech's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Dec. 2023 )
=28900.00/491.814
=58.76

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price to Tangible Book=Market Cap/Tangible Equity
=Market Cap/(Total Stockholders Equity-Preferred Stock-Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

D&D Pharmatech Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of D&D Pharmatech's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

D&D Pharmatech (XKRX:347850) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » D&D Pharmatech Inc (XKRX:347850) » Definitions » Price-to-Tangible-Book
Comparable Companies
Traded in Other Exchanges
N/A
Address
4th floor, 24, Pangyo-ro 255beon-gil, Bundang-gu, Gyeonggi-do, Sampyeong-dong, I&C Building, Seongnam-si, KOR
Website
http://www.ddpharmatech.com
D&D Pharmatech Inc is a company that comprises of experts in the field of bio-new drug research and development and technology commercialization, including basic scientists in the pharmaceutical biofield, manufacturing quality control (CMC) experts, and clinical development and technology transfer experts. Other business areas include the development of positron emission tomography (PET) imaging biomarkers conducted by Precision Molecular Inc. a 100% subsidiary, and single-cell sequencing related to degenerative brain diseases conducted by Valted Seq, Inc. The company utilizes drug delivery technologies such as PEGylation technology, which helps extend the administration interval using PEG and various chemicals, and platform technology that converts injectable drugs into oral preparations.

D&D Pharmatech (XKRX:347850) Headlines

No Headlines